WST * Stock Overview
Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 2/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
West Pharmaceutical Services, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$6,410.79 |
52 Week High | US$6,410.79 |
52 Week Low | US$5,692.00 |
Beta | 1.01 |
11 Month Change | 7.40% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | -25.28% |
5 Year Change | n/a |
Change since IPO | -22.55% |
Recent News & Updates
Recent updates
Shareholder Returns
WST * | MX Life Sciences | MX Market | |
---|---|---|---|
7D | 7.4% | 0% | 0% |
1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how WST * performed against the MX Life Sciences industry.
Return vs Market: Insufficient data to determine how WST * performed against the MX Market.
Price Volatility
WST * volatility | |
---|---|
WST * Average Weekly Movement | n/a |
Life Sciences Industry Average Movement | 0% |
Market Average Movement | 0% |
10% most volatile stocks in MX Market | 0% |
10% least volatile stocks in MX Market | 0% |
Stable Share Price: WST *'s share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine WST *'s volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1923 | 10,600 | Eric Green | www.westpharma.com |
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components.
West Pharmaceutical Services, Inc. Fundamentals Summary
WST * fundamental statistics | |
---|---|
Market cap | Mex$452.19b |
Earnings (TTM) | Mex$10.13b |
Revenue (TTM) | Mex$58.32b |
45.9x
P/E Ratio8.0x
P/S RatioIs WST * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
WST * income statement (TTM) | |
---|---|
Revenue | US$2.88b |
Cost of Revenue | US$1.87b |
Gross Profit | US$1.00b |
Other Expenses | US$503.40m |
Earnings | US$499.60m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 6.90 |
Gross Margin | 34.87% |
Net Profit Margin | 17.37% |
Debt/Equity Ratio | 7.4% |
How did WST * perform over the long term?
See historical performance and comparisonDividends
0.3%
Current Dividend Yield12%
Payout RatioDoes WST * pay a reliable dividends?
See WST * dividend history and benchmarksWest Pharmaceutical Services dividend dates | |
---|---|
Ex Dividend Date | Nov 13 2024 |
Dividend Pay Date | Nov 20 2024 |
Days until Ex dividend | 10 days |
Days until Dividend pay date | 17 days |
Does WST * pay a reliable dividends?
See WST * dividend history and benchmarks